We are live on
!
Find out more
Commonwealth Equity Services Portfolio holdings
AUM
$71.6B
1-Year Est. Return
21.08%
This Fund
S&P 500
This Quarter
Est. Return
-3.27%
1 Year Est. Return
+21.08%
3 Year Est. Return
+64.42%
5 Year Est. Return
+73.55%
10 Year Est. Return
+239.11%
AUM
$43.7B
AUM Growth
-$654M
(-1.5%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
3.54%
Top 10 Holdings %
Top 10 Hldgs %
18.76%
Holding
3,868
New
224
Increased
1,970
Reduced
1,386
Closed
163
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$55.2M |
| 2 |
iShares Core International Aggregate Bond Fund
IAGG
|
+$52.4M |
| 3 |
iShares Gold Trust
IAU
|
+$49.7M |
| 4 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$42M |
| 5 |
First Trust Rising Dividend Achievers ETF
RDVY
|
+$38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$51.8M |
| 2 |
Organon & Co
OGN
|
+$31.2M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$22.3M |
| 4 |
DWEQ
AdvisorShares Dorsey Wright Alpha Equal Weight ETF
DWEQ
|
+$22.3M |
| 5 |
iShares MSCI EAFE Growth ETF
EFG
|
+$22.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.86% |
| 2 | Financials | 5.98% |
| 3 | Healthcare | 4.98% |
| 4 | Consumer Discretionary | 4.84% |
| 5 | Industrials | 3.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
Kartoon Studios
TOON
$34.3M
| $40K | ﹤0.01% |
4,014
-5,395
| -57% | -$50.4K |
|
3602
Q32 Bio
QTTB
$450M
| $40K | ﹤0.01% |
739
+28
| +4% | +$1.74K |
|
|
VIEW
3603
DELISTED
View, Inc. Class A Common Stock
VIEW
| $40K | ﹤0.01% |
363
+148
| +69% | +$22.4K |
|
|
RGLS
3604
DELISTED
Regulus Therapeutics
RGLS
| $39K | ﹤0.01% |
13,100
+1,200
| +10% | +$3.12K |
|
|
LHDX
3605
DELISTED
Lucira Health, Inc. Common Stock
LHDX
| $39K | ﹤0.01% |
+11,000
| New | +$54K |
|
3606
AquaBounty Technologies
AQB
$4.68M
| $38K | ﹤0.01% |
1,030
-866
| -46% | -$30.1K |
|
3607
Cognition Therapeutics
CGTX
$82.3M
| $38K | ﹤0.01% |
+13,890
| New | +$53.5K |
|
|
DPRO
3608
Draganfly
DPRO
$156M
| $38K | ﹤0.01% |
+647
| New | +$23.9K |
|
3609
Atossa Therapeutics
ATOS
$22.8M
| $37K | ﹤0.01% |
2,019
-10
| -0.5% | -$203 |
|
3610
Momentus
MNTS
$88.7M
| $37K | ﹤0.01% |
+1
| New | +$38.5K |
|
3611
Team
TISI
$77.7M
| $36K | ﹤0.01% |
+1,636
| New | +$17K |
|
|
BIOL
3612
DELISTED
Biolase, Inc.
BIOL
| $35K | ﹤0.01% |
40
+21
| +111% | +$19.4K |
|
3613
Cytosorbents Corp
CTSO
$22.6M
| $34K | ﹤0.01% |
10,969
-1,054
| -9% | -$3.77K |
|
|
EMX
3614
DELISTED
EMX Royalty
EMX
| $34K | ﹤0.01% |
16,019
| – | – |
|
|
ATHX
3615
DELISTED
Athersys, Inc. Common Stock
ATHX
| $34K | ﹤0.01% |
2,271
-80
| -3% | -$1.67K |
|
|
NEWP
3616
New Pacific Metals
NEWP
$833M
| $33K | ﹤0.01% |
10,621
-1,639
| -13% | -$5.02K |
|
3617
Trevi Therapeutics
TRVI
$2.49B
| $33K | ﹤0.01% |
+15,000
| New | +$15.5K |
|
3618
XWELL
XWEL
$8.87M
| $33K | ﹤0.01% |
1,460
+753
| +107% | +$20.2K |
|
3619
GT Biopharma
GTBP
$11.7M
| $32K | ﹤0.01% |
372
+4
| +1% | +$353 |
|
3620
NN Inc
NNBR
$272M
| $32K | ﹤0.01% |
11,265
| – | – |
|
3621
Phunware
PHUN
$44M
| $32K | ﹤0.01% |
+235
| New | +$32.6K |
|
3622
CuriosityStream
CURI
$139M
| $31K | ﹤0.01% |
+10,796
| New | +$43.3K |
|
3623
Precision BioSciences
DTIL
$188M
| $31K | ﹤0.01% |
+342
| New | +$46.5K |
|
|
RDHL
3624
Redhill Biopharma
RDHL
$3.85M
| $30K | ﹤0.01% |
12
+1
| +9% | +$2.37K |
|
3625
Avalo Therapeutics
AVTX
$976M
| $29K | ﹤0.01% |
14
-4
| -22% | -$10K |
|
Similar funds
Commonwealth Equity Services's Q1 2022 Portfolio in Review
As of Q1 2022, Commonwealth Equity Services held 3,868 positions worth $43.7B, down 1.5% from $44.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Commonwealth Equity Services deployed $1.55B of net new capital in Q1 2022, opening 224 new positions and adding to 1,970 existing holdings. Its largest new stake was Shell: 319,280 shares worth $17.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $51.8M trimmed.
- Commonwealth Equity Services's largest Q1 2022 buy was Shell: 319,280 shares worth $17.5M.
- Commonwealth Equity Services added most to iShares Core S&P 500 ETF in Q1 2022, an estimated $55.2M increase.
- Commonwealth Equity Services's biggest Q1 2022 reduction was Vanguard Total International Bond ETF, cutting an estimated $51.8M.
- Commonwealth Equity Services fully exited Xilinx Inc in Q1 2022, selling an estimated $8.28M.
- Commonwealth Equity Services's ten largest holdings make up 19% of its $43.7B portfolio in Q1 2022.
- Commonwealth Equity Services opened 224 new positions and closed 163 in Q1 2022.
- Commonwealth Equity Services's portfolio value fell 1.5% quarter-over-quarter to $43.7B.
Based on Commonwealth Equity Services's 13F filing for Q1 2022, filed 4 May 2022.